COc1ccc(N2CCN(C(c3cccs3)C(C)NC(=O)c3ccc4c(c3)OCO4)CC2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?